Findings

What do systematic reviews say?

130 questions · 137 findings · 36 reviews · Musculoskeletal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 4.4%GRADE not reported 3 · 2.2%Very low 18 · 13.1%Low 55 · 40.1%Moderate 41 · 29.9%High 14 · 10.2%

Intervention not reported

Joint mobility Range of motion Scale from 0°‐135° (higher number reflects better outcome) · people with neurological conditions1

1 finding from 1 review

Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
no estimate extracted
18 studies · 549 participants
High

Intervention not reported

Participation restrictions 100 mm return to usual work activities VAS (higher score reflects better outcome) · people with non‐neurological conditions1

1 finding from 1 review

Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 129 participants
Low

Intervention not reported

Activity limitations 18‐point upper limb scale (higher score reflects better outcome) · people with neurological conditions1

1 finding from 1 review

Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 237 participants
Low

Intervention not reported

Joint mobility Range of motion Scale from 0°‐90° (higher number reflects better outcome) · people with non‐neurological conditions1

1 finding from 1 review

Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
no estimate extracted
18 studies · 865 participants
High

Intervention not reported

Quality of life 160‐point Burn Specific Health Scale‐Brief questionnaire (higher score reflects better outcome) · people with non‐neurological conditions1

1 finding from 1 review

Stretch for the treatment and prevention of contractures 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 97 participants
Moderate

Celecoxib vs NSAIDs

Physical function · patients with rheumatoid arthritis

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 849 participants
Low

Celecoxib vs placebo

Physical function · patients with rheumatoid arthritis

1 finding from 1 review

Celecoxib for rheumatoid arthritis 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 706 participants
Low

Intervention not reported

Quality of life on a 0 to 100 scale. Various quality of life scales. (higher score is better)

1 finding from 1 review

Aquatic exercise for the treatment of knee and hip osteoarthritis 2016 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 1027 participants
Moderate

Mobile bearing vs fixed bearing prosthesis

Function ‐ measured as KSS function Knee Society Score, function. Scale from 0 to 100 (higher scores indicates better function) · patients with posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and…

1 finding from 1 review

Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative… 2015 · Cochrane Headline outcomes only
no estimate extracted
14 studies · 1865 participants
Low

Mobile bearing vs fixed bearing prosthesis

Health‐related quality of life (physical) · patients with posterior cruciate retaining total knee arthroplasty for postoperative functional status in patients with osteoarthritis and…

1 finding from 1 review

Mobile bearing vs fixed bearing prostheses for posterior cruciate retaining total knee arthroplasty for postoperative… 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 498 participants
Low

Summary of findings table 4: refining rehabilitation: three months of postoperative night splinting with hand therapy vs hand therapy alone

Total active extension at 3 months Major outcome group 3 (early objective measurement) Total active extension (TAE) of MCPJ, PIPJ and DIPJ; higher value indicates loss of extension and a worse outcome · 210 participants with Dupuytren's disease of the fingers in 2 studies (225 digits reported across all studies) (Collis 2013;…

1 finding from 1 review

Surgery for Dupuytren's contracture of the fingers 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 225 participants
Low

Intervention not reported

Quality of life (at study completion) EuroQol (VAS) from 0 to 200 mm; higher score means better function · People with hip or knee osteoarthritis

1 finding from 1 review

High‐intensity versus low‐intensity physical activity or exercise in people with hip or knee osteoarthritis 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 214 participants
Very low

Traditional NSAIDs vs placebo

Pain (short term) WOMAC scale from 0 to 20 points (higher is worse pain). · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
850 participants
High

COX‐2 NSAIDs vs placebo

BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
193 participants
Moderate

COX‐2 NSAIDs vs placebo

BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
349 participants
High

COX‐2 NSAIDs vs placebo

BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

COX‐2 NSAIDs vs placebo

Radiographic progression · patients with axSpA (AS and nr‐axSpA)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Traditional NSAIDs vs placebo

BASDAI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
190 participants
Moderate

Traditional NSAIDs vs placebo

BASFI Scale from 0 to 100 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
356 participants
High

Traditional NSAIDs vs placebo

BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found